|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-2-12
|
|
pubmed:abstractText |
Finding the optimal strategy for Pneumocystis carinii prophylaxis in patients with human immunodeficiency virus infection can be problematic. Several prophylactic regimens are available, but their relative efficacy and tolerance are not well understood.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
156
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
177-88
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8546551-AIDS-Related Opportunistic Infections,
pubmed-meshheading:8546551-Dapsone,
pubmed-meshheading:8546551-Dose-Response Relationship, Drug,
pubmed-meshheading:8546551-Humans,
pubmed-meshheading:8546551-Logistic Models,
pubmed-meshheading:8546551-Multivariate Analysis,
pubmed-meshheading:8546551-Odds Ratio,
pubmed-meshheading:8546551-Pentamidine,
pubmed-meshheading:8546551-Pneumonia, Pneumocystis,
pubmed-meshheading:8546551-Randomized Controlled Trials as Topic,
pubmed-meshheading:8546551-Survival Analysis,
pubmed-meshheading:8546551-Toxoplasmosis,
pubmed-meshheading:8546551-Treatment Outcome,
pubmed-meshheading:8546551-Trimethoprim-Sulfamethoxazole Combination
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
|
|
pubmed:affiliation |
Division of Geographic Medicine and Infectious Diseases, New England Medical Center Hospitals, Boston, Mass, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Meta-Analysis
|
